Stock data
Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI) reported revenue of US$0.00M and net income of -US$512.54M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$555.34M | -US$512.54M | — |
| 2024 | US$0.00M | — | -US$487.34M | -US$422.77M | — |
| 2023 | US$330.53M | — | -US$196.70M | -US$145.22M | — |
| 2022 | US$105.06M | — | -US$340.74M | -US$325.99M | — |
| 2021 | US$48.66M | — | -US$295.75M | -US$290.58M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$3.60M | -US$127.55M | — |
| 2026-03-31 | — | -US$128.45M | — |
| 2025-12-31 | — | -US$128.55M | — |
| 2025-09-30 | — | -US$126.90M | — |
| 2025-06-30 | US$0.00M | -US$124.12M | — |
| 2025-03-31 | — | -US$132.97M | — |
| 2024-12-31 | US$0.00M | -US$114.75M | — |
| 2024-09-30 | US$0.00M | -US$107.19M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.